Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRM5 | P41594 | 6/20 | 0.38 |
| ▸ | LDHA | P00338 | 1/20 | 0.38 |
| ▸ | TGFBR1 | P36897 | 8/20 | 0.36 |
| ▸ | ENPP3 | O14638 | 1/20 | 0.33 |
| ▸ | HPGDS | O60760 | 1/20 | 0.33 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.33 |
| ▸ | IRAK4 | Q9NWZ3 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21397943 | 0.96 | LDHA (0.40) | GRM5LDHATGFBR1ENPP3IRAK4 | |
| SCHEMBL18015496 | 0.87 | LDHA (0.48) | GRM5LDHATGFBR1HPGDS | |
| SCHEMBL18015498 | 0.86 | LDHA (0.40) | GRM5LDHATGFBR1ENPP3MAPK14 | |
| SCHEMBL20006932 | 0.83 | GRM5 (0.41) | GRM5 | |
| SCHEMBL18015497 | 0.81 | GRM5 (0.42) | GRM5LDHATGFBR1MAPK14 | |
| SCHEMBL21020819 | 0.81 | LDHA (0.43) | GRM5LDHATGFBR1 | |
| SCHEMBL20007323 | 0.81 | LDHA (0.45) | LDHAENPP3IRAK4 | |
| SCHEMBL21398063 | 0.81 | HPGDS (0.46) | GRM5TGFBR1HPGDS | |
| SCHEMBL21398036 | 0.79 | LDHA (0.42) | LDHAHPGDS | |
| SCHEMBL22563336 | 0.79 | LDHA (0.45) | LDHAENPP3IRAK4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11136343-B2 | Binuclear metal complexes for use as emitters in organic electroluminescent devices | MERCK PATENT GMBH (DE) | 2021-10-05 | — | — | US | disclosed |
| EP-3515925-B1 | BINUCLEAR METAL COMPLEXES FOR USE AS EMITTERS IN ORGANIC ELECTROLUMINESCENT DEVICES | MERCK PATENT GMBH (DE) | 2020-10-21 | — | — | EP | disclosed |
| US-20190292210-A1 | BINUCLEAR METAL COMPLEXES FOR USE AS EMITTERS IN ORGANIC ELECTROLUMINESCENT DEVICES | MERCK PATENT GMBH (DE) | 2019-09-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190292210-A1 | BINUCLEAR METAL COMPLEXES FOR USE AS EMITTERS IN ORGANIC ELECTROLUMINESCENT DEVICES | AP2M1, MCU, AP3M1 | GRM5 1797/4885LDHA 2122/4885TGFBR1 3855/4885 |
| US-11136343-B2 | Binuclear metal complexes for use as emitters in organic electroluminescent devices | AP2M1, MCU, AP3M1 | GRM5 1797/4885LDHA 2122/4885TGFBR1 3855/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.